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CyclopamineNeural crest induction is the result of the combined action at the neural plate border of FGF, BMP, and Wnt
signals from the neural plate, mesoderm and nonneural ectoderm. In this work we show that the expression
of Indian hedgehog (Ihh, formerly named Banded hedgehog) and members of the Hedgehog pathway occurs at
the prospective neural fold, in the premigratory and migratory neural crest. We performed a functional
analysis that revealed the requirement of Ihh signaling in neural crest development. During the early
steps of neural crest induction loss of function experiments with antisense morpholino or locally grafted
cyclopamine-loaded beads suppressed the expression of early neural crest markers concomitant with the
increase in neural and epidermal markers. We showed that changes in Ihh activity produced no alterations
in either cell proliferation or apoptosis, suggesting that this signal involves cell fate decisions. A temporal
analysis showed that Hedgehog is continuously required not only in the early and late speciﬁcation but
also during the migration of the neural crest. We also established that the mesodermal source of Ihh is im-
portant to maintain speciﬁcation and also to support themigratory process. By a combination of embryological
andmolecular approaches our results demonstrated that Ihh signaling drives in the migration of neural crest
cells by autocrine or paracrine mechanisms. Finally, the abrogation of Ihh signaling strongly affected only
the formation of cartilages derived from the neural crest, while no effects were observed on melanocytes.
Taken together, our results provide insights into the role of the Ihh cell signaling pathway during the
early steps of neural crest development.
© 2012 Elsevier Inc. All rights reserved.Introduction
The neural crest (NC), a vertebrate transient and multipotent
embryonic cell population, is generated at the lateral borders of
the neural plate. The NC cells delaminate from the dorsal neural
tube and migrate extensively to several parts of the embryo, giving
rise to a wide variety of cell types, including melanocytes, cartilage,
connective tissue, neurons and glia of the peripheral nervous sys-
tem, and neuroendocrine cells (Le Douarin and Kalcheim, 1999).
The combined action of FGF, BMP and Wnt signals that originated
from the neural plate, mesoderm and nonneural ectoderm are inte-
grated at the neural plate border to induce and specify the neural
crest cells (reviewed in Aybar and Mayor, 2002; Basch et al., 2004;
Sauka-Spengler and Bronner-Fraser, 2006; Steventon et al., 2005).
It has been demonstrated that these secreted molecules mediate tis-
sue interactions during the early steps of neural crest development.
These signals ﬁrst activate neural border speciﬁers, then the neural, INSIBIO(CONICET-Universidad
el de Tucumán, Argentina.
).
rights reserved.crest speciﬁers are triggered (e.g. Snail1, Snail2, FoxD3, Sox9-10, etc.)
during the NC premigratory phase (Meulemans and Bronner-Fraser,
2004), and later these genes are essential for further NC development
involving NC speciﬁcation maintenance or cell migration. Our under-
standing of the intricate regulatory network remains preliminary.
Additional signals are also required to support the initial develop-
ment of the neural crest, such as the juxtacrine signal Notch/Delta, reti-
noic acid, or noelin-1 (Barembaum et al., 2000; Endo et al., 2002; Glavic
et al., 2004).
The roles and the relative importance of each cell signaling
involved in the process of neural crest induction are still controver-
sial. The participation of BMP as a neural crest inducer appears to be
insufﬁcient (LaBonne and Bronner-Fraser, 1998; Liem et al., 1995;
Marchant et al., 1998; Nguyen et al., 1998) while the role of Wnt
as an inducer has been demonstrated for different animal models
(Deardorff et al., 2001; Garcia-Castro et al., 2002; Heeg-Truesdell and
Labonne, 2006; Saint-Jeannet et al., 1997; Wu et al., 2003). The plural-
ity of signaling molecules required for neural crest induction is not
completely understood, but has introduced the idea that some signals
could control particular processes or induce speciﬁc cell precursors
among the multiple cell populations derived from this tissue.
100 T.H. Agüero et al. / Developmental Biology 364 (2012) 99–113Genetic and pharmacological research has demonstrated that
Hedgehog (Hh) signaling is essential for the correct development
of facial and neural crest-derived structures in the avian embryo
(Benouaiche et al., 2008). The experimental reduction of Sonic
hedgehog signaling affected the proliferation and survival of cells
in the chicken neural tube and cranial neural crest (Ahlgren and
Bronner-Fraser, 1999; Ahlgren et al., 2002). Studies conducted in
mammalian embryos have shown that the severity of craniofacial
defects related to holoprosencefaly correlates with the stage in which
interruption in Shh signaling occurs (Chiang et al., 1996; Cordero
et al., 2004). In the zebraﬁsh embryo Hh signaling is also required for
cranial neural crest morphogenesis and chondrogenesis (Wada et al.,
2005). In the absence of Hh signaling through inactivation of the
Hh receptor Smoothened (Smo) a complete loss of cranial skeletal
elements in zebraﬁsh embryos was observed (Chen et al., 2001).
Cartilage elements were lost or mislocalized after experimental
treatments with cyclopamine, an alkaloid antagonist of Hh signal-
ing, administered to whole embryos during the gastrulation period
(Eberhart et al., 2006). Recently, through the characterization of con/
disp1mutants, it was demonstrated that multiple and temporally sepa-
rated Hh-signaling events are required for the development of neuro-
cranial skeleton in zebraﬁsh. In these mutant embryos neural crest
cell condensations failed tomaintain the expression of key transcription
factors for chondrogenesis (Schwend and Ahlgren, 2009).
The three members of the Hh family of secreted factors, Sonic
hedgehog (Shh), Indian hedgehog (Ihh, orthologous to the mammalian
Indian hedgehog and formerly called Banded hedgehog), and Desert
hedgehog (Dhh, orthologous to the mammalian Desert hedgehog
and formerly called Cephalic hedgehog) were found in Xenopus em-
bryos (Ekker et al., 1995). Shh the most studied member in all spe-
cies, plays crucial roles in animal developmental processes and in
the homeostasis of adult tissues (Chari and McDonnell, 2007; Ruiz
i Altaba et al., 2002; Wang et al., 2007). In Xenopus, Shh is required
for neural tube patterning (for a review see Ruiz i Altaba et al.,
2003), during limb development and regeneration (Endo et al.,
1997; Endo et al., 2000; Yakushiji et al., 2009), in hypaxial muscle de-
velopment (Martin et al., 2007), axonal guiding (Gordon et al., 2010),
and during amphibian intestinal remodeling (Ishizuya-Oka et al.,
2006). On the other hand, Ihh and Dhh displayed novel and distinct ex-
pression patterns. Interestingly, Ihh expressionwas observed in periph-
eral regions of the neural plate and, at that time, it was implicated in
the direct induction of the cement gland (Ekker et al., 1995) and in en-
dochondral ossiﬁcation but the precise role of Ihh signaling in Xenopus
neural crest development has yet to be elucidated.
Here, we investigated the role of the Ihh signaling pathway in the
early development of the neural crest in Xenopus embryos. Single
and double in situ hybridization revealed that Ihh and different com-
ponents of the Hh pathway are expressed in the prospective neural
crest. Gain- and loss-of-function experiments showed that Ihh sig-
naling is speciﬁcally involved in the early induction of the neural
crest precursors while the speciﬁcation of Shh-dependent structures
remains unaffected. A detailed analysis was carried out to establish the
temporal requirement of Ihh signaling. A combined embryological and
molecular approach enabled us to show the participation of Ihh during
neural crest migration. Collectively, we describe ﬁndings that offer
an insight into the Ihh signaling role during neural crest induction,
speciﬁcation and migration in the amphibian embryo.
Material and methods
Embryonic manipulation, RNA microinjection and lineage tracing
Embryos were obtained by standard procedures (Aybar et al., 2003)
and staged according to Nieuwkoop and Faber (1967). Tissue dissections
were performed as previously described (Aybar et al., 2003; Bonano
et al., 2008); mRNA synthesis, microinjection, and lineage tracing wereperformed as described (Aybar et al., 2003; Bonano et al., 2008). In
vitro transcribed mRNA was synthesized from pT7TSXbhh (Ekker et
al., 1995), pT7TSXbhhN (Lai et al., 1995), and pT7TSXbhhΔN-C (Lai et
al., 1995) by standard procedures.
Cyclopamine treatments
In order to assess Hh activity, resin (Bio-Rex RG 501-8X resin,
Bio-Rad, USA) or Heparin-Sepharose (Amersham, USA) beads were
soaked with 20–50 μMof cyclopamine (N-aminoethyl aminocaproyl
dihydrocinamoyl cyclopamine, LC Laboratories, USA) and grafted
into embryos as previously described (Bonano et al., 2008; Honore
et al., 2003). Cyclopamine-soaked beads were implanted in the
right neural fold region (stages 11.5, 12, 14, and 18), or in the right
branchial arch region (stage 23) and the ﬁnal position of beads
was carefully examined under a stereoscopic microscope after the
in situ hybridization procedure. BSA- or vehicle-soaked beads were
grafted as control in sibling embryos at the same position.
Morpholino antisense oligonucleotide and DNA constructs
A morpholino antisense oligonucleotide (IhhMO) was designed
and synthesized against Xenopus laevis Ihh including the initiation
start site (from +1 to +24 bp) with the sequence 5′-CAGCACAA
CCTTGGGCAACTGCAT-3′ (Gene Tools, LLC). Doses of 10–25 ng/embryo
were microinjected with a lineage tracer into one blastomere at the
8- or 16-cell stage embryos. A control antisensemorpholino oligonu-
cleotide (CoMO) composed of a random sequence (5′-CCTCTTACCT
CAGTTACAATTTATA-3′, Gene Tools, LLC) was injected as a control.
The Ihh ORF from pT7TSIhh was used as a template for DNA con-
structs and in vitro mRNA synthesis. For the rescue of morpholino
knock-down experiments a DNA construct was prepared by changing
only the codon sequence targeted by the IhhMO antisense oligonucleo-
tide. Special care was taken to mutate the DNA sequence without
changing the wild type Ihh amino acid sequence. This construct,
named CRIhh (CR, Codon Replacement), introduced 6 mismatches
in the nucleotide sequence recognized by the morpholino and was
made by high ﬁdelity PCR using the following primers: 5′-GGATCC
ATGCAACTACCCAAAGTCGTTCTGCTTCTC-3′ and 5′-CTCGAGTCAGCT
TTCCAACTGGACAATTC-3′ (underlined, BamHI and XhoI restriction
sites, respectively). The PCR products were puriﬁed, A-tailed and cloned
into pTOPO-TA (pCR II-TOPO) (Invitrogen) to produce pTOPOIICRIhh
which was BamHI/XhoI-digested and ligated into a pCS2+ vector
digested with EcoRI/XhoI. Both fusion constructs were sequenced on
both strands at junction sites by automated DNA sequencing.
In order to test the efﬁcacy of IhhMO in vivo, a IhhGFP fusion was
generated by high ﬁdelity PCR using pT7TSIhh as the template and
the following primers: 5′-GGATCCATGCAGTTGCCCAAGGTTGTGC-3′
(underlined, BamHI restriction site) and 5′-CCATGGTGCCTCCAG
TCTTGGCAGCGG-3′ (underlined, NcoI restriction site). A fragment
containing the N-region of Ihh encoding 196 amino acid residues of
Ihhwas cloned into the pTOPO-TA vector, ampliﬁed and then cloned
directionally into BamHI and NcoI pCS2+EGFP vector to produce
the IhhGFP construct. In vitro transcribed mRNA of this construct
was co-injected with different amounts of IhhMO and the GFP ﬂuo-
rescence was observed under a Leica ﬂuorescence stereomicroscope.
An additional construct, named CRIhhGFP, was synthesized to comple-
ment the testing of IhhMO efﬁcacy. This construct carries 6 mismatches
and conserves the amino acid coding of wtIhh. The IhhGFP construct
was used as a template to amplify by high ﬁdelity PCR a 5′-region
that was fused to GFP. The primers used were: 5′-GGATCCATGCAac
TaCCCAAaGTcGTtCTGCTTCTC-3′ (underlined, BamHI restriction site;
lowercase and bold letters indicate mismatched bases) and 5′-
CCATGGTGCCTCCAGTCTTGGCAGCGG-3′ (underlined NcoI restriction
site).
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neural crest cells, the α3000 Snail2 promoter (Vallin et al., 2001) was
fused upstream to the full length CRIhh sequence. The α3000CRIhh
DNA construct was prepared from BamHI/XhoI digested pTOPO-CRIhh
and ligated into SB*XlpSlα3000-GFP plasmid (kindly donated by Dr.
Florence Broders). The α3000CRIhh plasmid was puriﬁed, diluted in
DEPC distilled water and 200–400 pg/embryo were microinjected into
one blastomere of 8- to16-cell embryos. Fluorescence was observed
since stage 13.Cartilage staining
For cartilage staining, injected and control embryos were ﬁxed in
formaldehyde at stages 45–47, washed with PBS and stained over-
night in 0.2% Alcian blue/20% acetic acid in ethanol. Embryos were
washed extensively with ethanol and bleachedwith a 1% KOH solution.
Finally, the embryoswerewashedwith 20% glycerol/2% KOH for 20 min
and dehydrated through a glycerol series into 80% glycerol. Skin and
muscles were manually dissected out and cranial cartilages were
isolated and photographed.RNA isolation from embryos and RT-PCR analysis
Total RNA was isolated from whole embryos or embryonic tissues
after microsurgery and cDNAwere synthesized as previously described
(Aybar et al., 2003). The primers designed for this study were: Ihh:
for: 5′-TACGGAATGCTGGCTAGG-3′, rev: 5′-GCTGAGTTAGAGGAG
CATAAGCC-3′; Smo: for: 5′-GGTGCCTTGGATCTGTTGGA-3′, rev: 5′-
TGGGTTCTGACACTGGATGC-3′; Ptc1: for: 5′-AGCACATGTTTGCACC
TGTC-3′, rev: 5′-GCTTCTTTGTTGGGTGGTGT-3′; Gli3: for: 5′-CTTCC
TGAACCCTCAGTTCC-3′, rev: 5′-CACTAGCAGATGAGCTGCTG-3′; MyoD:
for: 5′-GGACATGGAAGTCACTGAGG-3′, rev: 5′-ATACCTGCACTCAAC
TGTCC-3′; EF1α, for: 5′-CAGATTGGTGCTGGATATGC-3′, rev: 5′-ACTG
CCTTGATGACTCCTAG-3′; Sox10: for: 5′-CTTCCCCCTCATGCTCACTC-3′,
rev: 5′-TGCTTCACGAATGCACACAG-3′; Pax3: for: 5′-AGGAGACCGGATC
CATCAGA-3′, rev: 5′-TGGAGCTTACCGGGTTGTCT-3′; Ptc1 (qPCR): for:
5′-CCCTTTGGAGTTGCTGGAAG-3′, rev: 5′-CCGATGGGTTCAAACAAGGT-
3′; H4 (qPCR) for: 5′-GATAACATCCAGGGCATCAC-3′, rev: 5′-TAACCTCC
GAATCCGTACAG-3′. PCR ampliﬁcation with these primers was per-
formed over 28–30 cycles and the PCR products were analyzed
on 1.0% agarose gels. The gels were photographed and the semi-
quantitative analysis was carefully performed using the software
ImageJ (NIH, USA) as previously described (Tribulo et al., 2003). As
a control, PCR was performed with RNA that had not been reverse-
transcribed to check for DNA contamination. Real-time RT-PCR anal-
ysis of Ptc1 expression was performed using Ptc1 (qPCR) primers as
indicated and the Mezcla Real real-time PCR Mix (Biodynamics SRL,
Argentina) on a Bio-Rad CFX 96 (Bio-Rad, CA, USA). Retrotranscription
reaction for each sample was performed using random primers, 1 μg
of total RNA, 400 U MMLV-RT (Promega, USA) in a total volume of
30 μl. The real time PCR reaction mixture consisted of 10 μl of 2×
Mezcla Real mix, 100 nM forward and reverse Ptc1 (qPCR) primers,
and 2 μl of a 5× dilution of the RT reaction. The cycling conditions
were as follows: denaturation at 95 °C (10 s), annealing at 60 °C
(15 s), and extension at 72 °C (15 s). Reactions were optimized con-
sidering RNA and primers concentrations, reaction conditions, and
the fact that a single speciﬁc product was ampliﬁed as conﬁrmed
by melting curve analysis. All samples were run in triplicates and in-
cluded a control without template. The histograms in each ﬁgure are
representative cases of at least three independent experiments. In each
case, ornithine decarboxylase (ODC) was used as an internal reference
(data not shown). Each Ptc1 expression level has been normalized to
the level ofODC, and presented as a ratio to the neural crest Ptc1 expres-
sion level.In situ hybridization, TUNEL and immunohistochemistry
Antisense probes containing Digoxigenin-11-UTP or Fluorescein-
12-UTP were prepared for Ihh (Ekker et al., 1995), Gli3 (Marine et al.,
1997), Ptc1 (Koebernick et al., 2001; Perron et al., 2003), Smo
(Koebernick et al., 2001; Perron et al., 2003), Snail2 (Mayor et al.,
1995), Snail1 (Aybar et al., 2003), FoxD3 (Sasai et al., 2001), Msx1
(Tribulo et al., 2003), Sox2 (Dr. R.M.Grainger, personal communication),
Trp2 (Aoki et al., 2003), Pintallavis (also known as FoxA4a), (Ruiz i Altaba
et al., 1993), XK81a (Jonas et al., 1985), Paraxis (Carpio et al., 2004) and
Nkx6.2 (EST clone Xl461d15, kindly donated by Dr. Naoto Ueno) by in
vitro transcription. Specimens were prepared, hybridized, and stained
as previously described (Aybar et al., 2003). As control, sense probes
were synthesized and hybridized and did not produce any staining.
Apoptosis was detected by TUNEL staining according to the proce-
dure previously described (Hensey and Gautier, 1998; Tribulo et al.,
2004). For cartilage staining, embryos were ﬁxed at stages 45–47
and processed as previously described (Bonano et al., 2008). Rabbit
Polyclonal anti-phosphohistone-3 (Upstate Biotechnology) was used
to analyze mitotic cells according the method previously described
(Bonano et al., 2008; Turner and Weintraub, 1994).
Results
Expression of Ihh and Hh signaling pathway components in the neural
crest
Although the expression pattern of Ihh has already been reported
for Xenopus embryos (Ekker et al., 1995), we decided to analyze and
compare it with the expression of different components of the Hh
signaling pathway and with speciﬁc neural crest gene markers. Single
and double in situ hybridizations were performed in embryos at differ-
ent stages in order to complement previously published expression
patterns (Fig. 1). At the end of gastrulation (stage 12.5) the expression
of Ihh was observed at low levels in the dorsal anterior region of the
embryo. This expression occurred mostly in the anterior neural plate
and at the lateral border (Fig. 1A, arrowheads). At the midneurula
stage (stages 14–19) the expression increased in the neural plate and
neural plate borders (Fig. 1B) but was not observed along the midline
(arrow). Sibling embryos stained with sense Ihh probes showed no
labeling (Fig. 1B, inset). Transversal sections of stage 16 embryos
revealed that Ihh expression occurred mainly in the internal ectoder-
mal layers corresponding to the neural plate and prospective neural
crest and in the somitic mesoderm (Fig. 1I). At stage 14, a double in
situ hybridization of Ihh and the neural crest marker FoxD3 showed a
clear overlapping expression of both genes in the neural crest region
(Fig. 1M) in whole mount and in sectioned embryos (Fig. 1M’). At
stages 21–23, neural crest cells migrate and the expression of Ihh was
detected in the threemigrating cranial neural crest streams (Fig. 1C, ar-
rowheads) and in the otic and optic vesicles. From stage 22 onwards,
Ihh expression appeared localized in a conspicuous chevron-shaped
band within each somite (Fig. 1C). We also analyzed the expression
of other members of the Hedgehog signaling pathway. The whole-
mount in situ hybridization spatial analysis of Patched-1 (Ptc1) showed
that this receptor is expressed in early neurula stage embryos in the
anterior region of the neural plate and neural plate border (Fig. 1D).
Transverse sections revealed Ptc1 expression in the internal ectodermal
layer reminiscent of Ihh expression pattern (Fig. 1J). Smoothened (Smo)
transcripts were detectable at low levels from early neurula stage
(stage 12.5) onwards in a pattern similar to Ihh (Figs. 1E and F). At
mid-neurula stages (stages 15–19) the transverse sections showed
Smo expression in the internal ectodermal layer and in the underlying
mesoderm (Fig. 1K). By stage 22, expression was localized in the head
region, in the optic and otic vesicles and in the cephalic migratory
neural crest streams (Fig. 1G). The expression of Hedgehog effector
genes Gli2 and Gli3 was also analyzed by single and double in situ
Fig. 1. Xenopus laevis Ihh and Hh pathway components are expressed in the neural crest. (A, B, D–F and H) Dorsal views of Xenopus laevis embryos, anterior side is on the left. (C and
G) Lateral views. (A) Ihh transcripts are ﬁrst detected since the late gastrula stage (stage 12.5) in the lateral domains of the neural plate (arrowheads). (B) During neurulation Ihh is
expressed in the neural plate and in the neural plate border (arrowheads). No expression is observed in the neural plate midline (small arrow). No staining was observed in the
sense probe control (inset). The line (I) indicates the site of transverse section shown in I. (C) Stage 23 embryos show Ihh expression in the cranial neural crest migratory streams
(arrowheads), mandibular (m), hyoid (h) and branchial (b), in the optic (Op) and otic (Ot) vesicles, and in the somites (s, arrow). (D) Ptc1 in situ hybridization in a stage14 embryo.
Ptc1 expression is observed in the neural folds (arrowheads) and in the lateral neural plate, while expression is absent in the midline (arrow). No staining was observed using the
Ptc1 sense probe (inset). The line (J) indicates the site of transverse section shown in J. (E) Smo transcripts are observed in the neural plate and neural plate border in stage 12.5 embryos.
(F) Stage 14 embryos show Smo expression in the neural plate and neural folds (arrowheads). The line (K) indicates the site of transverse section shown in K. (G) In stage 22 embryos
Smo is expressed in the neural crest migratory streams (arrowheads), optic vesicle and somites. (H) Gli3 transcription factor is expressed in stage 13 embryos at the lateral border of the
neural plate and neural folds (arrowheads). The line (L) indicates the site of transverse section shown in L. (I–L) Transverse section of embryos displayed in B, D, F, and H showing Ihh (I),
Ptc1 (J), Smo (K), and Gli3 (L) expression. Asterisks indicate neural crest tissue; np, neural plate; n, notochord. (M–O) Double in situ hybridizations for Ihh (purple) and FoxD3 (tur-
quoise), Gli2 (purple) and FoxD3 (turquoise), and Gli3 (purple) and FoxD3 (turquoise). (M’–O’) Transverse sections of embryos displayed in M–O showing that Ihh, Gli2, and Gli3 expres-
sions overlap with FoxD3 in the neural crest territory. (P) Schematic diagram summarizing the expression of Ihh, Gli2, Gli3 and neural crest markers FoxD3, Snail1/2 in the left half of a
midneurula stage transversally sectioned embryo. Yellow (Ihh), red (Gli2) and green (Gli3) lines encircle the areas of expression for each gene. NP, neural plate; N notochord; NNE, non-
neural ectoderm; M, mesoderm; E, ectoderm.
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(Fig. 1H) and in the internal ectodermal layer at midneurula stages
(Figs. 1L and O). Gli2 transcripts were observed in the neural plate
and neural plate border overlapping with the expression of the
FoxD3 marker in the most lateral domain of Gli2 expression (Figs.
1N, N’). Gli3 expression was found more lateral than Gli2 and over-
lapping with FoxD3 expression in its central domain of expression
(Figs. 1O and O’).
We also analyzed the expression of Ihh and members of the
Hedgehog pathway by RT-PCR in neural crest, intermediate mesoderm
or non-neural ectodermexplants isolated from embryos atmid-neurula
stage (stage 16). As the intermediatemesoderm interacts with the neu-
ral crest region during neurulation (Bonano et al., 2008; Steventon et al.,
2009), we considered it interesting to establish the expression of
Hedgehog components in this tissue. The results conﬁrmed that Ihhand members of the Hedgehog cell signaling pathway Ptc1, Smo,
and Gli3 genes are expressed in the neural crest tissue (Fig. 2A).
Ihh, Ptc1, Smo andMyoD expression was detected in the intermediate
mesoderm. Moreover, we independently analyzed Ptc1 expression
levels by qPCR as readout of Hedgehog signaling in different regions
of stage 13 embryos. We were able to detect Ptc1 expression that is
indicative of an active Hedgehog signaling pathway in the neural
crest tissue. In comparison with the neural crest Ptc1 levels, the noto-
chord, intermediate mesodermal tissue, and the non-neural ectoderm
showed almost similar expression levels. The neural plate showed the
highest expression level, reaching almost 3-fold the neural crest level.
We conclude that Ihh and the Hedgehog Smo and Gli genes are
expressed in the neural crest, that the Ihh signaling is active in the
neural crest and that the Ihh signal is also available from the subjacent
mesoderm.
Fig. 2. Analysis of Ihh and Hhmembers' expression. (A) RT-PCR analysis of the expression
of Ihh, Smo, Ptc1, Gli3 and MyoD in neural crest, intermediate mesoderm and non-neural
ectoderm explants. Explants were dissected out from stage16 embryos (see Material
and methods). EF1α, loading control. (B) Ptc1 expression levels were analyzed as a read-
out of Hedgehog signaling activity in different embryonic regions, as indicated in C. Each
Ptc1 expression level has been normalized to the level of ODC, and presented as a ratio
to the neural crest Ptc1 expression level. (C) Schematic drawing depicting a transverse
section of a typical midneurula embryo indicating the dissected explants: 1, NC, neural
crest explants; 2, IM, intermediate mesodermal explants; 3, NNE, non-neural ectoderm;
4, NP, neural plate; 5, N, notochord.
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The expression patterns of Ihh and Hedgehog pathway components
strongly suggest that Ihh signaling could have a role during the initial
steps of neural crest development. We investigated the activity of Ihh
by examining the effects of knocking down its expression using an
antisense morpholino oligonucleotide directed against the initial
codons of Ihh (IhhMO). We ﬁrst analyzed the expression of GFP fu-
sion constructs. IhhGFP-injected embryos (Figs. 3A and A’) and con-
trol morpholino- and IhhGFP-coinjected embryos (Figs. 3B and B’)
showed GFP ﬂuorescence. Then we analyzed IhhMO oligonucleotide
efﬁciency and conﬁrmed that IhhMOwas able to inhibit the translation
of the GFP-tagged form of Ihh in a dose-dependent manner (IhhGFP,
Figs. 3C and D). We also prepared an IhhGPF fusion construct carrying
a 6-bp mutation in the morpholino recognition site (CRIhhGFP). The
expression of this construct was not affected when it was coinjected
with IhhMO at the same doses (Figs. 3E and F).
To assess the participation of Ihh signaling during neural crest
induction, embryos were injected at the 8-cell stage in one dorsal
blastomere with IhhMO (25 ng/embryo) (Figs. 3G–U) or an equivalent
amount of a control morpholino (CoMO, Fig. 3V). The embryos injected
with CoMO showed normal morphology and expression of the neural
crest marker FoxD3 (Fig. 3V, 100%, n=29), while embryos injected
with equivalent amounts of IhhMO failed to form the neural fold and
showed an inhibition of FoxD3 and Snail2 expression at the injected
side (Fig. 3G, 72% n=98 and 3H, 75% n=120; Snail1 not shown, 71%
of inhibition n=32). In the IhhMO injected embryos the neural plate
markers Sox2 (Fig. 3I, 66%, n=45) and the epidermal marker XK81a
were expanded (Fig. 3J, 69% of expansion, n=57), probably as aconsequence of the reduction in the neural crest, and no overlapping
between the neural plate and the epidermis was observed by double
in situ hybridization of Sox2 and XK81a markers (Fig. 3K, reduced NC
domain in 78% of embryos, n=27). In order to rule out the possibility
of effects on mesodermal tissue we evaluated the expression of the
mesodermal marker Paraxis (Carpio et al., 2004). We observed no
effect on Paraxis expression in the injected side when embryos
were microinjected in one dorsal blastomere of 8–16 cell embryos
(Fig. 3L, 93%, n=27), which indicates that the effects produced by
IhhMO were directed only to the ectodermal tissue. When embryos
were injected targeting the microinjection to the mesoderm (vegetative
region of blastomere D1.1, Hirose and Jacobson, 1979) in one ventral
blastomere the expression of Paraxis was found to be slightly reduced
(Fig. 3M, 91%, n=35). These results show that Ihh depletion in the
ectoderm promotes a speciﬁc loss of neural crest progenitors, thus
suggesting that this cell signal is involved in the early speciﬁcation
of the neural crest cells.
To evaluate the speciﬁcity of the morpholino effects, we decided to
determine whether the phenotype of Ihh-depleted embryos could be
rescued by restoring the Ihh function. We co-injected an Ihh construct
(CRIhh) carrying a 6-bp mutation within the recognition motif of
IhhMO in order to avoid hybridization between the morpholino and
the coinjected mRNA. When IhhMO was co-injected with CRIhh mRNA
a strong rescue in FoxD3 and Snail2 expression (Fig. 3N, 72% n=98
and 3O, 70% n=80)was observed. This effectwas speciﬁcally produced
by the coinjection of Ihh mRNA but not by the coinjection of unrelated
mRNAs like GFP mRNA (not shown). Thus, we concluded that IhhMO
was able to speciﬁcally knock down Ihh expression and therefore
abolish its activity. Besides, the co-injection of IhhMO with wtIhh,
NIhh (not shown) and a Snail2-promoter driven CRIhh construct re-
stored to normal the expression levels of the neural crest markers
FoxD3 and Snail2 (Fig. 3P 86%, n=77and 3Q, 81%, n=76). In order to
rule out the possibility that Ihh knock-out could affect the speciﬁcation
of the embryonic midline, we simultaneously evaluated by double in
situ hybridization the expression of the FoxD3 marker gene along
midline markers Nkx6.2 and Pintallavis (FoxA4a). We observed that
while neural crest expression of FoxD3 was strongly reduced the ex-
pression of midline markers remained unaffected (Fig. 3R, 84% n=32
and 3S, 85% n=35, respectively). The effect on neural crest induction
was rescued by the co-injection of CRIhh and by the microinjection of
Shh mRNA targeted to the neural plate border. In both cases, the in-
crease in Ihh activity or the ectopically targeted activity of Shh at the
neural plate border rescued neural crest induction without affecting
embryonic midline speciﬁcation (Fig. 3T, 93% n=30 and Fig. 3U, 89%
n=28).
We also analyzed the effects on neural crest speciﬁcation of the Ihh
dominant negative construct IhhΔN-C. This construct was found to
block in vivo the activity of Ihh and NIhh (Lai et al., 1995). We observed
that the overexpression of IhhΔN-C mRNA (1–3 ng/embryo) dimin-
ished the expression of FoxD3 (Fig. 4A, 59% n=49) and Snail2 neural
crest markers (Fig. 4B, 55%, n=56) and increased the neural plate
and epidermis territories expressing Sox2 (Fig. 4C, 48% n=34) and
XK81a (Fig. 4D, 51% n=39), respectively. The effect of IhhΔN-C was
rescued when wtIhh and NIhh were coinjected (Fig. 4E, 81% n=53
and Fig. 4F, 62% n=55). Taken together, the effect of IhhMO and
IhhΔN-C overexpression indicates that Ihh signaling is required during
the initial steps of neural crest formation.
In order to establish whether Ihh signaling might participate in the
control of neural crest speciﬁcation, we microinjected Ihh and NIhh
mRNAs into the animal pole of a dorsal blastomere of 4-cell stage
embryos. NIhh is an active N-terminal fragment of Ihh that mimics
its function (Lai et al., 1995). Ihh injection led to an expansion of the
neural crest territory analyzed by the expression of FoxD3 (Fig. 5A,
71% n=62), Snail2 (Fig. 5B, 69% n=65) and Snail1 (not shown, 77%
n=43). This effect also produced a concomitant reduction in the Sox2
(Fig. 5C, 57% n=67) neural plate marker and the XK81a epidermal
104 T.H. Agüero et al. / Developmental Biology 364 (2012) 99–113marker (Fig. 5D, 55% n=64). Similar effects on neural crest expression
were observed when we overexpressed CRIhh (not shown, 84%
n=67) and NIhh mRNAs (Figs. 5E–H, FoxD3 61% n=80; Snail2 58%
n=72; Sox2 60% n=53, and Xk81a 55% n=54). With the overexpres-
sion of wtIhh, double in situ hybridization for Sox2 and XK81a showed
that the expansion of neural crest territory was accompanied by aconcomitant reduction in the neural plate and epidermal domains
(Fig. 5I, 68% n=28). The Snail2 promoter-driven overexpression of Ihh
(Fig. 5J) also led to a marked increase in neural crest territory evidenced
by the expression of the FoxD3marker (Fig. 5K, 100% n=64 and Fig. 5L
97%, n=36). No changes were observed in the expression of the mid-
line marker Nkx6.2 in these α3000CRIhh-injected embryos (Fig. 5L).
Fig. 4. Ihh is required for neural crest speciﬁcation (continuation). (A–F) Analysis of the overexpression of dominant negative IhhΔN-C on neural crest speciﬁcation. (A and B)
IhhΔN-C-injected embryo shows a diminished expression of FoxD3 and Snail2 markers. (C and D) Expression of the neural plate marker Sox2 and the epidermal marker XK81a is
expanded on the IhhΔN-C-injected side. (E and F) FoxD3 expression was rescued in embryos co-injected with wtIhh (E) or NIhh construct (F). Arrowheads indicate the injected
side. Brackets indicate the width of the neural plate (C), and the width of the neural plate plus the neural crest domain (D).
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as a result of the ectopic expression of Ihh is produced by the transfor-
mation of the epidermis and of part of the neural plate region into
prospective neural crest cells.
Ihh signaling is not involved in the control of cell proliferation or apoptosis
in the neural crest
It has been previously shown that the apoptotic process is involved
in the development of the neural crest (Honore et al., 2003; Tribulo
et al., 2004). Moreover, the Hedgehog cell signaling pathway has been
implicated in the control of cell proliferation in many cell systems also
including neural crest cells (Ahlgren et al., 2002; Dyer and Kirby, 2009;
Fu et al., 2004; Marcelle et al., 1999), etc.). We observed signiﬁcant
changes in the area expressing neural crest markers when we activated
or blocked the expression or function of Ihh. There is a possibility that
these changes were produced by changes in the cell proliferative status
or by changes in the apoptotic process. To rule out such possibility we
therefore decided to investigate cell proliferation and apoptosis during
Ihh gain or loss of function.
The microinjection of Ihh or IhhMO produced no detectable changes
in the cell proliferation status assessed by the detection of a phosphor-
ylated form of H3 histone (Fig. 6A n=24; Fig. 6C n=26).Wewere also
unable to ﬁnd signiﬁcant changes in apoptotic cell death evaluated by
TUNEL staining between the control side and the treated side of Ihh-
or IhhMO-injected embryos (Fig. 6B, 94% n=18; Fig. 6D 0%, n=21),
or in embryos injected with CoMO (0% increase in TUNEL staining,
n=20, not shown). Taken together, these results led us to conclude
that Ihh signaling does not play a role in the control of cell proliferationFig. 3. Ihh is required for neural crest speciﬁcation. (A–F) In vivo efﬁciency of Ihh antisense
ﬂuorescence stereoscopic microscope, anterior side is on the left. White arrows indicate the i
and shown in merged images. (A and A’) Embryo injected with mRNA encoding IhhGFP (1
(1 ng/embryo) and CoMO (30 ng/embryo). (C, C’, D and D’) Embryos injected with IhhGFP m
dose (2), 20 ng/embryo). No embryo shows GFP ﬂuorescence at a high dose of IhhMO. (E
Embryo injected with CRIhhGFP mRNA and a high dose (2) of IhhMO (20 ng/embryo). The exp
(G–V) Analysis of IhhMO effects on neural crest speciﬁcation. Dorsal views of Xenopus laevis e
injected embryos show inhibition of FoxD3 and Snail2 neural crest markers. (I and J) Expressi
IhhMO-injected side. The brackets indicate the width of neural plate (I), and the width of neur
genes evidenced that IhhMO led to the reduction in the prospective neural crest domain in th
pression of the mesodermal marker Paraxis. No effect was observed in a dorsal blastomere of
vegetative region of blastomere D1.1 produced a reduced Paraxis expression in the injected side
sion, respectively. (P and Q) The co-injection of CRIhh speciﬁcally driven by the Snail2 promote
Themicroinjection of IhhMO into a dorsal blastomere of stage 16 embryos decreases the expres
ble in situ hybridization, white arrowheads, Nkx6.2 and Pintallavis-FoxA4a). (T and U) The
directed co-injection of CRIhh (Q) or Shh to the neural fold region (U). (V) CoMO-injectedor apoptosis, and that the alterations observed in the neural crest terri-
tories after changes in the activity of the Ihh pathway could represent
ectodermal cell fate decisions.
Temporal analysis of Ihh requirement for neural crest induction
Antisense morpholino technology provides a very speciﬁc way of
inhibiting the expression of a single gene. However, this approach is
limited since it is difﬁcult to control the timing of morpholino activity.
In order to precisely control the moment of Ihh signaling blocking we
used the Hedgehog-speciﬁc antagonist cyclopamine. Cyclopamine is a
steroidal alkaloid found in the plant Veratrum californicumwhich inter-
rupts the hedgehog pathway activation by binding directly to the
Smoothened (Smo) transmembrane receptor (Chen et al., 2002).
We assessed the inhibition of Ihh signaling by using cyclopamine
speciﬁcally delivered at the neural plate border at three different
moments of development. To achieve this goal acrylic beads soaked
with different amounts of cyclopamine were grafted into the right
prospective neural plate border of stage 11.5 (Figs. 7A and B), stage
12 (late gastrula, Figs. 7C–G), and midneurula stage embryos (stage
14, Figs. 7I and J). Embryos were cultured until different stages and
the expression of gene markers was analyzed by in situ hybridization.
Treatment of stage 11.5 embryos with 20 μM cyclopamine-soaked
beads markedly downregulated Snail1 (Fig. 7A, 64% n=22), Snail2
(Fig. 7B, 56% n=18) and Msx1 (Fig. 7C, 66% n=18) expression in the
neural crest territory. A similar effect on the expression of the same
marker was observed when cyclopamine-soaked beads were grafted
at stage 12 embryos (Fig. 7D, FoxD3, 67% n=41, and Fig. 7E, Snail2,
56% n=43, respectively). The pharmacological inhibition bymorpholino oligonucleotide (IhhMO). Dorsal views of Xenopus laevis embryos under a
njected side. (A’–F’) Fluorescence and clear ﬁeld images of each embryo are superposed
ng/embryo) showing GFP ﬂuorescence. (B and B’) Embryo injected with IhhGFP mRNA
RNA (1 ng/embryo) and IhhMO (C and C’, low dose (1), 10 ng/embryo; D and D’, high
and E’) Embryo injected with CRIhhGFP mRNA showing GFP ﬂuorescence. (F and F’)
ression of CRIhhGFP was not affected by the presence of the morpholino oligonucleotide.
mbryos, anterior side is on the left. Arrows indicate the injected side. (G and H) IhhMO-
on of the neural plate marker Sox2 and the epidermal marker XK81a is expanded on the
al plate plus neural crest domain (J). (K) Double in situ hybridization for Sox2 and XK81a
e injected side. The brackets indicate the width of the neural crest domain. (L and M) Ex-
8–16 cell embryos (L). The targeting of IhhMO to the mesoderm by microinjection of the
(M). (N and O) Co-injection of IhhMO and CRIhhmRNA rescues FoxD3 and Snail2 expres-
r (α3000CRIhh) rescues the expression of FoxD3 and Snail2 neural crest markers. (R and S)
sion of FoxD3 in the neural crest but produces no effects on the midline markers (dou-
effects of IhhMO on the expression of the neural crest marker FoxD3 is rescued by the
embryos show normal expression of FoxD3.
Fig. 5. Ihh participates in the early neural crest speciﬁcation. Dorsal views of Xenopus laevis embryos, anterior side is on the left. Injected side is indicated by an arrowhead. wtIhh-
injected embryos show increased expression of FoxD3 (A) and Snail2 (B). The expression of the neural plate marker Sox2 (C) and the epidermal marker XK81a (D) appear reduced
on the injected side. (E–H) The injection of NIhhmRNA increases the expression of FoxD3 (E) and Snail2 (F) while the markers Sox2 (G) and XK81a are reduced (H). (I) Double in situ
hybridization for Sox2 and XK81a genes evidenced the expansion of the prospective neural crest domain in the injected side. The brackets indicate the width of the neural crest
domain. (J–L) The Snail2 promoter-driven (α3000CRIhh) overexpression of the CRIhh construct increases the expression of FoxD3 in the neural crest. The same embryo
shown in J was hybridized for FoxD3 and is depicted in K. (L) α3000CRIhh-injected embryos show increased FoxD3 expression and normal expression of NKx6.2 in the embryo
midline (double in situ hybridization). Brackets indicate the width of the neural plate (C and G), and the width of the neural plate plus the neural crest domain (D and H).
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marker Sox2 (Fig. 7F, 63% n=44) and XK81a (Fig. 7G, 61% n=39)
expressed in tissues adjacent to the neural crest. Although the
cyclopamine-soaked beads were implanted into the right neural plate
border and this location is far from the embryo midline, we decided
to test for possible effects on the midline gene marker Nkx6.2
(Fig. 7H). We observed no effects on Nkx6.2 expression while cyclo-
pamine local treatment only reduced the neural crest expression of
FoxD3 (Fig. 7H, 96% n=26). No effect on the expression of the neural
crest marker FoxD3 was observed when BSA-soaked beads were grafted
at stage 12 (Fig. 7I, 95% n=22).Fig. 6. Ihh gain- and loss-of-function produce no changes in cell proliferation and apoptosis. Dor
were visualized by whole-mount immunostaining using anti-phospho-Histone H3 antibody. W
Ihh- and IhhMO-injected sides show no changes in cell proliferation of apoptosis compared wiWhen cyclopamine-soaked beads were grafted on the neural
crest region at the midneurula stage (stage 14), a weaker effect
was observed on the treated side of the embryos and the expression
of neural crest markers FoxD3 and Snail2 showed only a mild but
consistent downregulation (Fig. 7J, 59% n=39, and Fig. 7K, 70%
n=30). No effects on the expression of FoxD3 was found when a
BSA-soaked bead was grafted on stage 14 embryos (Fig. 7L, 86%
n=21).
The analysis of the expression of the components of the Hedgehog
pathway suggested that this cell signaling could be active at the neu-
ral plate border during the earliest stages of neural crest inductionsal views ofXenopus laevis embryos, anterior side is on the left. (A and C) Themitotic nuclei
hite arrows indicate the injected side. (B and D) Apoptotic nuclei were labeled by TUNEL.
th the respective control sides. Black arrowhead indicates the injected side.
Fig. 7. Temporal requirement of Ihh signaling during early neural crest development. Dorsal views of Xenopus laevis embryos, anterior side is on the left. Stage 11.5 (A–C), 12 (D–H)
or 14 (J, K) embryos were grafted on the right neural fold with a cyclopamine-soaked bead. Embryos were cultured until stage 13 (A–C), 14 (D–H) or 17 (J and K), when the
expression pattern of marker genes was analyzed. Arrowheads indicate the grafted side. (A–C) Early treatment of neural folds with cyclopamine leads to a reduction in the
expression of neural crest markers Snail1 (A), Snail2 (B) andMsx1 (C). (D–H) Cyclopmine-soaked beads grafted in stage 12 also produced a decrease in the expression of neural
crest markers FoxD3, Snail2 (D and E) and an expansion of the neural plate (F) and prospective epidermis (G) on the treated side. Cyclopamine-soaked beads grafted on the
right side of embryos produced no change in the expression of the midline marker Nkx6.2 (double in situ hybridization). (J and K) Cyclopamine-loaded beads grafted at
stage 14 produced a less intense decrease in the expression of FoxD3 and Snail2 markers on the treated side. (I and L) No changes in the expression of FoxD3 were observed
when BSA-soaked beads were grafted on stage12 or stage14 embryos. (M) Neural plate border explants were dissected out at stage 11 and incubated until stage 13 in 3/8 NAM solution
or 3/8 NAM solution containing 20 μM cyclopamine, and the expression of Pax3 and Sox10 was analyzed by RT-PCR. (N) Quantiﬁcation of the gel is shown in M, where the results are
expressed as Relative Intensity (sample/EF1α×10).
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neural plate border explants by analyzing the expression of early
speciﬁcation neural crest gene markers (Fig. 7M). We assessed Pax3
and Sox10 gene markers as they are considered a neural plate border
speciﬁer and neural crest speciﬁer, respectively (Meulemans and
Bronner-Fraser, 2004). The neural plate border explants were dissected
out from stage 11 embryos and incubated in 20 μM cyclopamine until
stage 13 when they were processed for RT-PCR. Cyclopamine-treated
explants showed a reduced expression of both Pax3 and Sox10markers.Notably, the effect of cyclopamine on Sox10 was more intense as the
expression of this marker showed approximately a 3.5-fold reduc-
tion compared to control explants (Fig. 7M).
Thus, the pharmacological blockade by cyclopamine was able to
reproduce the phenotype obtained by the directed microinjection of
morpholino oligonucleotides, showing that Ihh activity is required
for the early steps of neural crest induction. Furthermore, these results
suggest that at midneurula stages the speciﬁcation of neural crest is
still in progress.
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It has been shown that the mesoderm plays a role in neural crest
speciﬁcation and maintenance (Bonano et al., 2008; Bonstein et al.,
1998; Mancilla and Mayor, 1996; Marchant et al., 1998; Monsoro-
Burq et al., 2003; Steventon et al., 2009). Our results suggest that
there is a later requirement for Ihh signaling during speciﬁcation in
the midneurula stages (Fig. 7). We decided to analyze the participation
of mesoderm since the early steps of neural crest induction and the
participation of Ihh signaling from the late gastrula to the late neurula
stages.
NC explants dissected at late gastrula stage (stage 12) and imme-
diately ﬁxed the expressed FoxD3 marker (Fig. 8B). FoxD3 expression
was observed both in explants that were dissected out at stage 12 and
in explants incubated until stage 16 containing (NC+M) or not (NC)
the underlying mesodermal tissue (Figs. 8C and D). When NC+M ex-
plants were incubated in the presence of 50 μM cyclopamine the
FoxD3 expression was downregulated (Fig. 8E).
A strong expression of FoxD3 was observed in neural crest explants
dissected at stage 14 or 17 and ﬁxed immediately (Figs. 8F and J).
When equivalent stage14 neural crest explants with no mesoderm
were cultured until the equivalent of stage 18, the expression of FoxD3
was notoriously reduced (Fig. 8G). Conversely, in the neural crest
explants containing the subjacent mesoderm (NC+M) the expressionFig. 8. Ihh signaling is necessary for neural crest maintenance. (A) Neural crest explants (N
mesoderm (NC+M) in the explants. Groups of explants were ﬁxed immediately after excis
until stages 16, 18 or 23 in the presence or absence of cyclopamine. (B, F and J) NC explants
dissection. (C and D) NC explants dissected from stage 12 embryos and cultured until stage
NC explants isolated at stage 12 and cultured until stage 16 in the presence of 20 μM cyclop
a mild inhibition of FoxD3 expression when they were cultured in the absence of mesoderm
NC+M explants. (I) Culture of NC+M explants dissected from stage 14 embryos in 20 μM
dissected at stage 17 without mesoderm and cultured until stage 23 lose FoxD3 expressio
required for the maintenance of speciﬁcation. (M) Cyclopamine treatment of NC+M explaof FoxD3 was strong and similar to control explants (Fig. 8H). When
these NC+Mexplants were incubatedwith 50 μMcyclopamine the ex-
pression of FoxD3 almost completely disappeared (Fig. 8I). At later
stages, in NC explants that were dissected containing no mesoderm at
stage 17 and cultured to equivalent stage 23, the expression of FoxD3
was lost (Fig. 8K), while the explants containing mesoderm conserved
the expression of this gene (Fig. 8L). In contrast, in the NC+M explants
cultured until stage 23 in 50 μM cyclopamine the expression of FoxD3
was abolished (Fig. 8M).
Taken together, these ﬁndings strongly suggest that mesodermal
requirement increases from gastrulation to late neurula stages and
that Ihh signaling is required during the same period.
Ihh signaling is required for neural crest migration
Ihh transcripts were found to be expressed in the premigratory
and migratory neural crest (Figs. 1 and 2). Moreover, our NC explants
culture approach revealed that themesoderm–neural crest relationship
is progressively required from early to late neurulation stages to sustain
the speciﬁcation status of neural crest cells (Fig. 8). In these NC explants
a Hedgehog signal is also required. All these ﬁndings suggest that Ihh
signaling might also participate in the migratory process. We blocked
the Hedgehog pathway using cyclopamine-loaded beads implanted in
the neural crest region of stage 18 embryos, when neural crest cellC) were prepared by dissection of the neural crest only, or by including the underlying
ion (left), at stages 12, 14 or 17. Groups of explants (NC only or NC+M) were cultured
removed from embryos at different stages express FoxD3 when ﬁxed at the moment of
16 express FoxD3 at similar levels regardless of the presence of the mesoderm. (D) The
amine lose FoxD3 expression. (G) NC explants dissected from stage 14 embryos show
al tissue. (H) A strong expression of FoxD3, similar to control explants, was observed in
cyclopamine abolishes the expression of FoxD3 neural crest marker. (K) NC explants
n compared with NC+M explants (L), revealing that signals from the mesoderm are
nts isolated from stage 17 embryos produced inhibition of FoxD3 expression.
Fig. 9. Ihh signaling is required for neural crest migration. The anterior side of the embryos is on the left. (A) Stage 18 embryos were grafted on the right neural crest region with a 20 μM cyclopamine-soaked bead. Embryos were cultured until
stages 21–23 and the expression pattern of marker genes was analyzed. FoxD3 expressing neural crest cells show arrested migration and accumulated laterally to the hindbrain. The leading edge of migration is indicated by dashed lines. (C)
Embryos grafted with control BSA-soaked beads show normal neural crest migration compared with the control untreated side (D). (E) Schematic drawing indicating the experimental procedure for the analysis of Ihh participation during
neural crest migration. One-cell stage embryos were microinjected with CoMO, IhhMO, α3000CRIhh construct and lineage tracer. When embryos reached stage 17, neural crest explants containing the underlying mesodermal tissue (NC+M)
or neural crest tissue alone (NC) were grafted into wild type or IhhMO injected host embryos. (F and F’) CoMO-injected NC+M explants show normal migration when transplanted into wild type host embryos. (G and G’) IhhMO-injected NC
explants grafted into normal wild type host embryos show normal neural crest migration. (H and H’) IhhMO- and α3000CRIhh-coinjected NC+M explants grafted into wild type embryos show normal neural crest migration. The CRIhh
construct rescued neural crest and produced a normal migratory cell population. The mesodermal source of Ihh is able to support the migration. (I and I’) IhhMO-injected NC explants grafted onto IhhMO-injected host embryos show no
migration. (J and J’) IhhMO- and α3000CRIhh-coinjected NC+M explants grafted onto wild type embryos show normal neural crest migration. (K and K’) Wild type NC explants grafted into IhhMO-injected host embryos show normal mi-














110 T.H. Agüero et al. / Developmental Biology 364 (2012) 99–113migration is about to begin.We observed that cyclopamine produced
a clear effect on neural crest cell migration as in the treated side the
front of migration, revealed by FoxD3 expression, migrated less than
in the control side (Fig. 9B, 72% n=42). Control BSA- or saline
solution-soaked beads produced no effect on neural crest migration
(Fig. 9C, 81% n=33).
As Ihh was also expressed in the mesoderm underlying the neural
crest (Figs. 1 and 2), we then wanted to determine the role of this
mesodermal source in the migratory process. In order to assess its
participation, we performed a transplantation approach transferring
neural crest tissue (NC) or neural crest tissue containing the under-
lying mesodermal tissue (NC+M) to stage 17 wild type- or IhhMO-
injected embryos. Donor embryos were microinjected with IhhMO,
α3000CRIhh or CoMO and FDA as a lineage tracer and neural crest
explants were grafted orthotopically onto host embryos (Fig. 9E).
When CoMO-injected neural crest grafts were transplanted to normal
wild type embryos a normal cranial neural crest migration pattern
was observed (Fig. 9F, 86%, n=18). Strikingly, when IhhMO-injected
NC neural crest explants containing no underlying mesoderm were
grafted onto normal host embryos themigration pattern was complete-
ly normal, suggesting that the Ihh signal emanating from the subjacent
mesoderm rescued neural crest migration (Fig. 9G, 75%, n=20). The
migration of neural crest cells from a IhhMO-injected NC+M graft
was rescued by the co-injection of the α3000CRIhh/GFP constructs
(Fig. 9H, 78%, n=18).When lineage tracer-injected NC normal explants
were transplanted to IhhMO-treated embryos a normal neural crest
migration could be seen (Fig. 9K, 77%, n=22). In contrast, IhhMO-
injected NC grafts transplanted into IhhMO-injected embryos showed
no cranial neural crest migration (Fig. 9I, 100%, n=19). Additionally,
the migratory behavior of NC+M explants taken from IhhMO-injected
embryoswas rescued by the coinjection ofα3000CRIhh and a normalmi-
gratory pattern in the cephalic neural crest was observed (Fig. 9J, 90%,
n=18).
Taken together, these observations indicate that Ihh signaling is
required for the normal migration of cranial neural crest cells. Further-
more, our ﬁndings suggest that Ihh could act in both an autocrine and a
paracrine manner to support neural crest migration.Ihh is required for craniofacial derivatives development
We decided to investigate the effect of Ihh knockout on neural
crest derivatives after the injection of Ihhmorpholino antisense oligo-
nucleotides (Fig. 10A). The analysis of cartilage morphology by Alcian
Blue staining of IhhMO-injected embryos showed a severe reduction
in craniofacial cartilages in the BhMO-injected side (Fig. 10A, 66%
n=80). The gross morphology analysis of craniofacial cartilages
revealed that neural crest-derived cartilages (Meckel's, ceratobranchial
and ceratohyal cartilages) were markedly reduced. The injection of
CoMO showed no effect on craniofacial cartilage size or morphology
(Fig. 10F). The effect of IhhMO was rescued by the co-injection of
Snail2 promoter-directed CRIhh construct (α3000CRIhh, Fig. 10B, 79%
n=56). We also assessed the late participation of Hh signaling in cra-
niofacial cartilage development. We grafted cyclopamine beads in the
right branchial arch region of stage 23 embryos. We observed that in
the cyclopamine-treated side the development of craniofacial cartilages
was severely affected (Fig. 10D, 95%, n=44). The control grafting of
BSA-loaded beads in the branchial region of sibling embryos produced
no effects (Fig. 10E, 100%, n=40). We also observed that the injection
of IhhMO produced no effects either on Trp2 expression (Fig. 10I, 100%
n=40) or on melanocyte pattern (Fig. 10G, H, 100% n=31). In the
IhhMO treated embryos no signiﬁcant differences in melanocyte
number or pattern were observed between injected and control
sides. These results show that Ihh signaling is required for the normal
formation of speciﬁc neural crest derivatives such as cartilage but not
for the formation of other derivatives like melanocytes.Discussion
Neural crest development is a highly orchestrated process that
requires the contribution of various cell signaling pathways and in-
volves the participation of different embryonic tissues. In this study,
we showed that early induction, maintenance of speciﬁcation and
migration require Ihh cell signaling. Signiﬁcant progress has been
achieved in understanding the role of Shh in different developmental
processes and animal models but the roles of other Hedgehog mole-
cules (i.e. Ihh and Dhh, formerly named Banded hedgehog and Cephalic
hedgehog, respectively) during embryogenesis are less known.
We report here the analysis of the Ihh expression pattern and the
expression of Hh pathway members Ptc-1, Smo and the effectors Gli2
and Gli3. The comparative analysis of the expression with neural crest
and neural plate markers conﬁrmed the expression of these genes in
the neural crest during the late gastrula and neurula stages. These
results extend and complement the previously reported expression
pattern (Ekker et al., 1995) and suggest that new roles could be as-
sumed by Ihh at the neural plate border that are distinct from
those attributed to Shh (Brewster et al., 1998; Franco et al., 1999;
Lopez et al., 2003; Ruiz i Altaba, 1998).
The expression patterns of Ihh and Hh components in the neural
fold suggest that this signaling pathway plays a role in neural crest
speciﬁcation in Xenopus embryos. Ihh knock-down using a speciﬁc
morpholino oligonucleotide or the pharmacological inactivation by
cyclopamine-soaked beads grafted on the neural fold caused deple-
tion of neural crest precursors. In contrast, the overexpression of Ihh
produced an increase in the size of the neural crest territory. These
results are in agreement with the ﬁndings of Franco et al. (1999),
who showed an increased expression of neural fold prepattern
gene Zic2 after the injection of Ihh or Shh in 2-cell stage embryos.
They also reported that Ihh or Shh injection increased the size of
the neural plate and reduced the expression of the Snail2 neural crest
marker (Franco et al., 1999). This represents an unexpected result as
Zic2 gene is anti-neurogenic and a promoter of neural crest induction
(Brewster et al., 1998; Nakata et al., 1998). In this work, extreme care
was taken to direct Ihh overexpression to the lateral aspect of the
neural plate and the neural plate border region by the injection of
one dorsal blastomere of 8- to 16-cell stage embryos, or using the
Snail2 promoter (α3000, Vallin et al., 2001) to drive the expression
of an Ihh construct. Moreover, the cyclopamine-soaked beads were
implanted speciﬁcally into the neural fold region. These experimen-
tal approaches allowed us to assess the participation of Ihh signaling
exclusively in the neural crest while the speciﬁcation of dorsal mid-
line remained unaffected. However, we also showed that the ectopic
action of Shh at the neural plate border could rescue the loss of Ihh at
the neural fold to support neural crest initial speciﬁcation. Our results
suggest that Ihh possibly has a role in the neural plate that could be
different from the one in the neural crest. This suggests the possibility
that Ihh could activate molecular mechanisms at the neural fold that
support the counterbalance that apparently exists during the speciﬁca-
tion of ectodermal cells that control the neural versus neural crest fate
decision, manifested when one territory increases its size at the expense
of another. The lack of change in the cell proliferation or apoptosis status
in Ihh- or IhhMO-injected embryos reinforces the participation of the Ihh
signaling cascade as a switch in cell fate decisions that take place in the
ectoderm during the induction of the neural crest cell population. Con-
versely, an increased apoptosis rate has been described in chick embryo
when Shh was inhibited (Ahlgren and Bronner-Fraser, 1999).
The early requirement of Hedgehog signaling for a correct develop-
ment of the neural crest appears to be a feature of amphibian embryos.
In the chick embryo the increased activity of Shh abrogates NC induction
(Liem et al., 1995; Selleck et al., 1998). In addition, the disruption of
dorsal–ventral neural tube patterning by cyclopamine-blocking of
Hedgehog signaling after NC ablation inducedmigratory cardiac neural
crest-like cells (Hutson et al., 2009). It has been shown for zebraﬁsh
Fig. 10. Ihh participates in the formation of neural crest derivatives. (A–F) Craniofacial cartilages, Alcian blue staining. (A) IhhMO-injected side of stage 45 embryos (arrowhead) present a
marked reduction of Meckel's, ceratohyal and ceratobranchial cartilages. (B) The coinjection of IhhMO and speciﬁc Snail2 promoter-driven (α3000) expression of CRIhh rescues normal
cartilages morphology. (C) Schematic representation of IhhMO effects on Xenopus head cartilages. (D) Stage 23 embryos were grafted on the right branchial arch region with 20 μM
cyclopamine-soaked beads, cultured until stage 46 and stained with Alcian blue. The ceratobranchial cartilage was the most affected by this treatment. (E) Control BSA-soaked beads
grafted in the branchial region of stage 23 embryos produced no effect on craniofacial cartilages. (F) Control morpholino (CoMO)-injected embryos show no changes in cartilage
morphology. (G–I) IhhMO produced no effects on pigment cell development (G–H) or Trp2 expression (I) compared with their respective non-injected sides (G’, J and K). (A–F) Anterior
side is at the top. M, Meckel's cartilage; Ir, infrarrostral cartilage; CH, ceratohyal cartilage; BH, basihyal cartilage; CB, ceratobranchial cartilage.
111T.H. Agüero et al. / Developmental Biology 364 (2012) 99–113embryos that most neural crest-derived craniofacial cartilages are
lost or mislocalized by treatment with cyclopamine during the gas-
trulation period, but this requirement of Hh signaling is indirect and
acts by specifying the stomodeal ectoderm before the neural crest
cells arrive at its vicinity (Eberhart et al., 2006; Wada et al., 2005).
Cyclopamine treatments of zebraﬁsh embryos during early neurula-
tion and neural crest speciﬁcation also resulted in reduced mandibu-
lar cartilage (Schwend and Ahlgren, 2009). It has been suggested
that although genetic studies in zebraﬁsh have shown that Shh is in-
volved in the formation of craniofacial cartilages, this role could be
shared with Shhb (formerly named tiggy-winkle hedgehog, twhh),
which is expressed in a similar pattern (Wada et al., 2005). In agree-
ment with the published experimental data in zebraﬁsh studies, we
also found that late treatment with cyclopamine disrupts craniofa-
cial cartilage formation. However, more studies are needed to dis-
criminate between different Hedgehog signaling molecules since
Shh and Ihh are both expressed in the branchial arch region (Ekker
et al., 1995, this work) and also to determine their relative contribu-
tion to chondrogenesis.
To additionally understand the participation of Ihh signaling during
neural crest development, we evaluated the temporal requirement
of this signaling at different times of neural crest formation. Previous
studies have demonstrated that the competence window for Xenopus
neural crest induction is established from stages 10+ to 13 (Mancillaand Mayor, 1996). Our analysis using cyclopamine-treated stage 11
explants and cyclopamine-soaked beads grafted at stages 11.5, 12 and
14 and neural crest explants taken from stages 12, 14 and 17 embryos
showed that Ihh signaling requirement goes beyond the ectodermal
competence period and lasts until the midneurula stage. This agrees
with previous observations that demonstrated the requirement of
BMP, Wnt and Edn1 as maintenance signals from the subjacent meso-
derm that sustain the neural crest speciﬁcation status (Bonano et al.,
2008; Steventon et al., 2009). Whenwe analyzed the effects of cyclopa-
mine on neural fold explants at the onset of neural crest induction we
were able to establish that both Pax3, a gene considered a neural fold
speciﬁer, and Sox10, a neural crest speciﬁer (Meulemans and Bronner-
Fraser, 2004), showed a decreased expression. We found that Sox10
expression was more strongly inhibited than Pax3 expression, which
suggests that the Ihh signaling pathway is probably able to selectively
regulate certain components of the genetic cascade that controls neural
crest induction, although this requires further investigation.
Ihh is expressed in the premigratory andmigratory neural crest cells
in Xenopus embryos. Here we showed that Ihh signaling is continuously
required for neural crestmigration and that this signal functions in both
autocrine and paracrine modes. In contrast, in zebraﬁsh embryos it has
been shown that cyclopamine treatment during cranial neural crestmi-
gration caused little effects on the development of pharyngeal arch ele-
ments, revealing a differential requirement for Hh signaling (Schwend
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adhesion and migration in chick neural tube explants in vitro by a
mechanism independent from the Patched–Smoothened–Gli signaling
pathway, and independently of its mitogenic or inductive activities
(Testaz et al., 2001). In contrast, our results showing the blocking of
neural crest migration by cyclopamine-soaked beads suggest that
the canonical hedgehog signaling is required, as it is also indicated
by zebraﬁsh Smo and Gli mutations for the development of neural
crest-derived DRG neurons (Ungos et al., 2003).
In our transplantation assays the Ihh source located in the somitic
mesoderm was able to promote and maintain neural crest migration.
It has been demonstrated that the mesoderm is involved in the neural
crest initial induction (Bonstein et al., 1998; Marchant et al., 1998;
Steventon et al., 2009), and in recent years the relationship between
neural crest and surrounding tissues has increased in importance
since those tissues provide essential signaling molecules required for
migration and later development (Ahlgren and Bronner-Fraser, 1999;
Bonano et al., 2008; Brito et al., 2006; Kimmel et al., 2001; Steventon
et al., 2009)
In this work we showed that early Ihh abolition by the morpholino
oligonucleotide and a late cyclopamine treatment in the branchial
arch region at the end of neural crest migration (stage 23) impaired
the formation of cranial neural crest-derived cartilages, although no
changes were found in the generation of other trunk neural crest de-
rivatives such as pigment cells. This observation agrees with a previous
report that shows that Xenopus cranial neural crest cells are sensitive to
cyclopamine treatment while trunk neural crests are resistant to treat-
ment (Dunn et al., 1995). Species-speciﬁc requirements for Hh signals
appear to be operating since in zebraﬁsh embryos the genetic and
pharmacological inhibition of Hh signaling leads directly to loss of
dorsal root ganglia neurons derived from trunk neural crest, al-
though there were no obvious effects on the level of expression of
the crestin marker, on the pattern of neural crest migration or in
the development of pigment cells and ﬁn ectomesenchyme (Ungos
et al., 2003).
Our results support an early role for Ihh in the neural crest devel-
opment signaling based on the use of a speciﬁc morpholino to abolish
its expression and temporal analysis of cyclopamine local effects. This
leads us to propose that, among the multiplicity of signals operating
in the neural crest early speciﬁcation, Ihh signaling might participate
in the establishment of different cell subtypes in the premigratory
and migratory neural crest. Thus, the initial loss of the neural crest af-
fected the size of cranial neural crest-derived structures, and the late ef-
fect of cyclopamine suggest that Ihh is required for themolecular events
of craniofacial development, although this possibility requires further
investigation. In zebraﬁsh it has been shown that Hh-signaling is also
required for the expression of transcription factors involved in chon-
drogenesis and osteogenesis differentiation (Schwend and Ahlgren,
2009). In addition, in mouse embryos, Ihh (the mammalian homologous
of Xenopus Ihh) is expressed in the proximal region of Meckel's cartilage,
which is entirely of neural crest origin, undergoes endochondral ossi-
ﬁcation and contributes to sclerotic ossicles (Iwasaki et al., 1997).
Moreover, Ihh signaling also participates in the endochondral ossiﬁca-
tion during Xenopus limb formation (Moriishi et al., 2005).
In summary, our ﬁndings demonstrate the embryonic requirement
of Ihh signaling for neural crest development. However, further research
is necessary to understand the molecular mechanisms underlying its
participation in each neural crest event. The transcription factors Gli2
orGli3, in their activator or repressor forms, appear as interesting candi-
dates acting in the transduction of Ihh signaling in neural crest cells, but
such possibility still remains to be explored.
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